Netflix NFLX stock has upside – Buy The Dips on NFLX stock & here is why

Evelo dealt another blow with a PhII fail, plans for strategic alternatives

Evelo Biosciences is exploring strategic alternatives for its mid-stage psoriasis treatment after it reported that another psoriasis drug failed a Phase II clinical trial. Since

October 18, 2023

Incyte drops four early-stage programs from its pipeline as part of strategic review

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 31, 2024

Acetaminophen at moderate doses may alter heart function

The common painkiller acetaminophen was found to alter proteins in the heart tissue when used regularly at moderate doses, according to a new study conducted

April 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.